First-in-class medications target RA and type 2 diabetes Drug News: Effient, Endometrin, Jurnista Drug news: February 2010 Conjunctivitis, prostate cancer drugs debut New antibiotic, type 2 diabetes drugs hit market Heparin: new USP standards will reduce potency of some products Drug news: Doribax, Onglyza New options arrive for schizophrenia, rheumatoid arthritis and atrial fibrillation New generics: September 2009 Ontario lays charges against pharmacies, wholesalers and generic firms Ontario takes legal action against a number of parties after forensic audits revealed wide-scale fraud against the ODB plan. First Previous 5 6 7 Next Last
